CCEL Company Profile and Key Details
Cryo-Cell International, Inc.
CCEL Stock Price Chart
Stock Price Today
Cryo-Cell International, Inc. (CCEL) stock declined over -0.68%, trading at $7.35 on NASDAQ, down from the previous close of $7.40. The stock opened at $7.32, fluctuating between $7.20 and $7.61 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Company Information
| Employees | 82 |
| Beta | 0.51 |
| Sales or Revenue | $31.34M |
| 5Y Sales Change% | -0.04% |
| Fiscal Year Ends | November |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
Frequently Asked Questions
Cryo-Cell International, Inc. (NASDAQ: CCEL) stock price is $7.35 in the last trading session. During the trading session, CCEL stock reached the peak price of $7.61 while $7.20 was the lowest point it dropped to. The percentage change in CCEL stock occurred in the recent session was -0.68% while the dollar amount for the price change in CCEL stock was -$0.05.
The NASDAQ listed CCEL is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Cryo-Cell International, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Oleg Mikulinsky
Chief Information Officer
Dr. Joanne Kurtzberg M.D.
Medical Director and Member of Medical & Scientific Advisory Board
Mr. David I. Portnoy
Chairman & Co-Chief Executive Officer
Mr. Mark L. Portnoy
Co-Chief Executive Officer & Director
Ms. Jill M. Taymans
Chief Financial Officer & Vice President of Fin.
CCEL's closing price is 64.43% higher than its 52-week low of $4.47 where as its distance from 52-week high of $9.50 is -22.63%.
Number of CCEL employees currently stands at 82.
Official Website of CCEL is: https://www.cryo-cell.com
CCEL could be contacted at phone 813 749 2100 and can also be accessed through its website. CCEL operates from 700 Brooker Creek Boulevard, Oldsmar, FL 34677, United States.
CCEL stock volume for the day was 6.75K shares. The average number of CCEL shares traded daily for last 3 months was 22.92K.
The market value of CCEL currently stands at $59.26M with its latest stock price at $7.35 and 8.06M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com